ESAs to treat anemia—balancing the risks and benefits

被引：0
|
作者：
John Glaspy
机构：
[1] University of California Los Angeles David Geffen School of Medicine,
来源：
Nature Reviews Clinical Oncology | 2009年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Erythropoiesis-stimulating agents are widely used in patients with cancer; however, uncertainty persists over their effect on survival. This article discusses the results of a meta-analysis of randomized, controlled trials of these agents in patients with cancer.
引用
收藏
页码：500 / 502
页数：2
相关论文
共 50 条
  • [1] ESAs to treat anemia-balancing the risks and benefits
    Glaspy, John
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (09) : 500 - 502
  • [2] Balancing Risks and Benefits: Treat Bilateral Necks, But Omit the Tongue
    Zumsteg, Zachary S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 902 - 902
  • [3] Balancing risks and benefits
    Nature Reviews Cancer, 2013, 13 (2) : 81 - 81
  • [4] Does TREAT Give the Boot to ESAs in the Treatment of CKD Anemia?
    Singh, Ajay K.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (01): : 2 - 6
  • [5] Tamoxifen, balancing risks and benefits
    Bergman, L
    Benraadt, J
    vanLeeuwen, FE
    NETHERLANDS JOURNAL OF MEDICINE, 1996, 49 (06): : 228 - 234
  • [6] NSAIDs Balancing the Risks and Benefits
    Gorczyca, Pamela
    Manniello, Marina
    Pisano, Michele
    Avena-Woods, Carmela
    US PHARMACIST, 2016, 41 (03) : 24 - 35
  • [7] Balancing the risks and benefits in AMD
    Beaumont, PE
    Kang, HK
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 33 (01): : 108 - 110
  • [8] Balancing the Risks and Benefits of Rituximab
    Linos, Eleni
    JAMA INTERNAL MEDICINE, 2013, 173 (10) : 926 - 926
  • [9] ECT - BALANCING RISKS AND BENEFITS
    BROWN, JH
    BRITISH MEDICAL JOURNAL, 1980, 280 (6225): : 1228 - 1228
  • [10] Lithium: balancing risks and benefits
    Cookson, J
    BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 : 120 - 124
12345